NASDAQ:LQDA

Liquidia Technologies Stock Insider Trading

Healthcare > Biotechnology

Buy LQDA

*Your capital is at risk

$84.11

-2.69 (-3.10%)

At Close: Jul 31, 2026

Liquidia Technologies Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -96.74. In total, the insiders bought 213.67K and sold 1.63M LQDA shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-96.74
● Buy	213.67K shares
● Sell	1.63M shares
38% Buy Activity Strong Negative Correlation
Buy Signal Low Confidence Jul 10, 2026 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory negative Insider Power Score of -96.74. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Jul 13, 2026 Sell	Common Stock S-Sale	Moomaw Scott Chief Commercial Officer	Officer	8 864 Value: $634.0K
Jul 13, 2026 Sell	Common Stock S-Sale	Saggar Rajeev Chief Medical Officer	Officer	703 Value: $50.2K
Jul 13, 2026 Sell	Common Stock S-Sale	Saggar Rajeev Chief Medical Officer	Officer	9 223 Value: $659.6K
Jul 10, 2026 Buy	Common Stock M-Exempt	Kaseta Michael CFO And COO	C-Suite Officer	7 050 Value: $549.4K
Jul 10, 2026 Buy	Performance Stock Units M-Exempt	Krepp Sarah Chief Human Resource Officer	Officer	3 179 Value: $247.7K
Jul 10, 2026 Buy	Performance Stock Units M-Exempt	Boyle Dana Chief Accounting Officer	Officer	3 179 Value: $247.7K
Jul 10, 2026 Buy	Common Stock M-Exempt	Moomaw Scott Chief Commercial Officer	Officer	4 358 Value: $339.6K
Jul 10, 2026 Buy	Common Stock M-Exempt	Boyle Dana Chief Accounting Officer	Officer	3 179 Value: $247.7K
Jul 10, 2026 Buy	Common Stock M-Exempt	Krepp Sarah Chief Human Resource Officer	Officer	3 179 Value: $247.7K
Jul 10, 2026 Buy	Common Stock M-Exempt	Kaseta Michael CFO And COO	C-Suite Officer	5 829 Value: $454.3K
Jul 10, 2026 Buy	Performance Stock Units M-Exempt	Kaseta Michael CFO And COO	C-Suite Officer	7 050 Value: $549.4K
Jul 10, 2026 Buy	Performance Stock Units M-Exempt	Jeffs Roger Chief Executive Officer	CEO / President	14 333 Value: $1.12M
Jul 10, 2026 Buy	Restricted Stock Units M-Exempt	Adair Jason Chief Business Officer	Officer	3 907 Value: $304.5K
Jul 10, 2026 Buy	Common Stock M-Exempt	Saggar Rajeev Chief Medical Officer	Officer	3 531 Value: $275.2K
Jul 10, 2026 Buy	Performance Stock Units M-Exempt	Saggar Rajeev Chief Medical Officer	Officer	3 531 Value: $275.2K
Jul 10, 2026 Buy	Performance Stock Units M-Exempt	Schundler Russell General Counsel	Officer	6 409 Value: $499.5K
Jul 10, 2026 Buy	Performance Stock Units M-Exempt	Schundler Russell General Counsel	Officer	3 759 Value: $292.9K
Jul 10, 2026 Buy	Common Stock M-Exempt	Schundler Russell General Counsel	Officer	6 409 Value: $499.5K
Jul 10, 2026 Buy	Common Stock M-Exempt	Schundler Russell General Counsel	Officer	3 759 Value: $292.9K
Jul 10, 2026 Buy	Performance Stock Units M-Exempt	Adair Jason Chief Business Officer	Officer	2 475 Value: $192.9K
Jul 10, 2026 Buy	Performance Stock Units M-Exempt	Moomaw Scott Chief Commercial Officer	Officer	4 358 Value: $339.6K
Jul 10, 2026 Buy	Performance Stock Units M-Exempt	Moomaw Scott Chief Commercial Officer	Officer	3 108 Value: $242.2K
Jul 10, 2026 Buy	Common Stock M-Exempt	Adair Jason Chief Business Officer	Officer	3 869 Value: $301.5K
Jul 10, 2026 Buy	Common Stock M-Exempt	Adair Jason Chief Business Officer	Officer	2 475 Value: $192.9K
Jul 10, 2026 Buy	Common Stock M-Exempt	Adair Jason Chief Business Officer	Officer	3 907 Value: $304.5K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT LIQUIDIA TECHNOLOGIES INC.

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisvill...

Read Full Profile Here